QA: Korro Bio Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001703647_2022_Korro_Bio_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001703647, Korro Bio Inc.

  xvar xval
0 AssetsCurrent 134,748,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,522,000
3 remainder_Assets 45,088,000
4 LiabilitiesCurrent 11,429,000
5 LiabilitiesNoncurrent 28,938,000
6 remainder_Liabilities 14,167,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 37,176,000
9 ResearchAndDevelopmentExpense 60,923,000
10 remainder_Expenses 1,045,000
11 remainder_Revenues 14,068,000
12 remainder_NetIncome 390,000
13 remainder_ComprehensiveNetIncome -89,000
  yvar yval
0 Assets 185,358,000
1 Liabilities 54,534,000
2 Expenses 99,144,000
3 Revenues 14,068,000
4 StockholdersEquity 130,824,000
5 NetIncome -84,686,000
6 ComprehensiveNetIncome -84,730,500
7 BaseVar 176,791,500
8 EconomicCapitalRatio 1.17

Edgar->Model Mapping

Feature Distribution

Change over Time